Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis (Q90241630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

review article

1 reference

title

Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

1 reference

Sherstin T Lommatzsch

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in respiratory disease

12 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

1753466620905272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

start time

1 January 2020

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Predicting outcome following pulmonary resection in cystic fibrosis patients

1 reference

12 December 2020

Pulmonary resection for complications of cystic fibrosis

1 reference

12 December 2020

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

12 December 2020

Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period

1 reference

12 December 2020

Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group

1 reference

12 December 2020

Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward

1 reference

12 December 2020

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

1 reference

12 December 2020

Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group

1 reference

12 December 2020

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

12 December 2020

Systematic review of N-acetylcysteine in cystic fibrosis

1 reference

12 December 2020

Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis

1 reference

12 December 2020

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

1 reference

12 December 2020

Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts

1 reference

12 December 2020

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

1 reference

12 December 2020

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission

1 reference

12 December 2020

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

12 December 2020

Cystic Fibrosis Adult Care

1 reference

12 December 2020

Invasive pneumococcal infections in adult lung transplant recipients

1 reference

12 December 2020

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

1 reference

12 December 2020

Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic.

1 reference

12 December 2020

Immunisation in the current management of cystic fibrosis patients

1 reference

12 December 2020

Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections

1 reference

12 December 2020

Regulation of airway surface liquid volume and mucus transport by active ion transport

1 reference

12 December 2020

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

1 reference

12 December 2020

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

1 reference

12 December 2020

Audit and feedback and clinical practice guideline adherence: making feedback actionable.

1 reference

12 December 2020

Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance

1 reference

12 December 2020

Risk factors affecting outcome and morbidity in the surgical management of bronchiectasis

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

1 reference

12 December 2020

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

1 reference

12 December 2020

Lung resection in cystic fibrosis: a survival analysis

1 reference

12 December 2020

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines: airway clearance therapies

1 reference

12 December 2020

Surgical treatment of bronchiectasis: a retrospective analysis of 790 patients

1 reference

12 December 2020

Cystic fibrosis and the thoracic surgeon.

1 reference

12 December 2020

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Alpha-1-antitrypsin deficiency

1 reference

12 December 2020

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

1 reference

12 December 2020

Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study

1 reference

12 December 2020

Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis

1 reference

12 December 2020

Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.

1 reference

12 December 2020

Lung transplantation in patients with prior cardiothoracic surgical procedures.

1 reference

12 December 2020

The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Thoracoscopic lobectomy and segmentectomy for infectious lung disease

1 reference

12 December 2020

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia

1 reference

12 December 2020

Macrolide antibiotics for cystic fibrosis

1 reference

12 December 2020

Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation

1 reference

12 December 2020

Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health

1 reference

12 December 2020

The bronchiectasis severity index. An international derivation and validation study

1 reference

12 December 2020

Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.

1 reference

12 December 2020

Lobectomy in patients with cystic fibrosis

1 reference

12 December 2020

Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection

1 reference

12 December 2020

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update

1 reference

12 December 2020

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines

1 reference

12 December 2020

Lung resection improves the quality of life of patients with symptomatic bronchiectasis

1 reference

12 December 2020

Infection prevention and control guideline for cystic fibrosis: 2013 update

1 reference

12 December 2020

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study

1 reference

12 December 2020

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

1 reference

12 December 2020

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial

1 reference

12 December 2020

Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis

1 reference

12 December 2020

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update

1 reference

12 December 2020

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

1 reference

12 December 2020

Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection

1 reference

12 December 2020

Streptococcus pneumoniae oropharyngeal colonization in children and adolescents with cystic fibrosis

1 reference

12 December 2020

Airway clearance techniques for bronchiectasis

1 reference

12 December 2020

Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis

1 reference

12 December 2020

Pneumococcal vaccines for cystic fibrosis.

1 reference

12 December 2020

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis

1 reference

12 December 2020

Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry

1 reference

12 December 2020

Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis

1 reference

12 December 2020

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

1 reference

12 December 2020

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

1 reference

12 December 2020

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.

1 reference

12 December 2020

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season

1 reference

12 December 2020

European Respiratory Society guidelines for the management of adult bronchiectasis

1 reference

12 December 2020

Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

1 reference

12 December 2020

The Prevalence and Significance of Staphylococcus aureus in Patients with non-Cystic Fibrosis Bronchiectasis

1 reference

12 December 2020

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients

1 reference

12 December 2020

Defining the sizes of airborne particles that mediate influenza transmission in ferrets

1 reference

12 December 2020

ECFS best practice guidelines: the 2018 revision

1 reference

12 December 2020

Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity

1 reference

12 December 2020

Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis

1 reference

12 December 2020

Work environment risks for health care workers with cystic fibrosis

1 reference

12 December 2020

Nebulised hypertonic saline for cystic fibrosis

1 reference

12 December 2020

Surgical management of non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews

1 reference

12 December 2020

Identifiers

DOI

10.1177/1753466620905272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

PubMed publication ID

32160809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32160809%20AND%20SRC:MED&resulttype=core&format=json